Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? (Q37682746)

22 August 2017

title

Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? (English)

1 reference

22 August 2017

1 reference

Tina Wang

1

1 reference

22 August 2017

Rebecca A Nelson

series ordinal

2

1 reference

22 August 2017

Alicia Bogardus

series ordinal

3

1 reference

22 August 2017

Frederic W Grannis

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

116

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

1518-1525

1 reference

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Predictors of enrollment in lung cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Results of Surgical Treatment in Patients with Stage IIIA Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Survival and prognostic factors of surgically resected T4 non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Survival after resection for primary lung cancer: a population based study of 3211 resected patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Late survival of non-small cell lung cancer patients with brain metastases. Influence of treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: a retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Prevalence of poor performance status in lung cancer patients: implications for research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

The effect of FDG-PET on the stage distribution of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24871

7 January 2021

Identifiers

DOI

10.1002/CNCR.24871

1 reference

release_3zdhali6rrdlzi24wdg3zt2mmi

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3zdhali6rrdlzi24wdg3zt2mmi

24 November 2022

mapped directly with Wikidata item

1 reference